Table 1 Baseline demographics and clinical characteristics of the study population
Variable | Total, n = 16 |
|---|---|
Age (mean ± SD, years) | 60.6 ± 10.5 |
Gender | |
Male | 12 (75%) |
Female | 4 (25%) |
Type 2 DM | 16 (100%) |
Duration of diabetes (mean ± SD, years) | 9.6 ± 4.8 |
Wagner classification | |
Grade 3 | 3 (18.8%) |
Grade 4 | 13 (81.2%) |
Follow-up (mean ± SD, months) | 10.8 ± 3.1 |
Comorbidities | |
Hypertension | 6 (37.5%) |
Ischemic heart disease | 4 (25.0%) |
Peripheral neuropathy | 14 (87.5%) |
Nephropathy | 7 (43.8%) |
Retinopathy | 8 (50.0%) |